Rizavasertib was a drug candidate originally developed by Abbott (now AbbVie). It is a pan akt Inhibitor. It is now used as an akt inhibitor tool compound.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.